Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy-Reference-Cited by-同舟云学术

Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy

Published:2010-01 Issue:1 Volume:117 Page:133-139.e2
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Khanna Dinesh,Chong Kelvin K.L.,Afifiyan Nikoo F.,Hwang Catherine J.,Lee Diana K.,Garneau Helene Chokron,Goldberg Robert A.,Darwin Christine H.,Smith Terry J.,Douglas Raymond S.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference38 articles.

1. Epidemiology and estimated population burden of selected autoimmune diseases in the United States;Jacobson;Clin Immunol Immunopathol,1997

2. The incidence of autoimmune thyroid disease: a systematic review of the literature;McGrogan;Clin Endocrin (Oxf),2008

3. Graves' disease;Weetman;N Engl J Med,2000

4. Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy;Smith;Thyroid,2008

5. Circulating mononuclear cells from euthyroid patients with thyroid-associated ophthalmopathy exhibit characteristic phenotypes;Douglas;Clin Exp Immunol,2007

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Graves disease: latest understanding of pathogenesis and treatment options;Nature Reviews Endocrinology;2024-07-22

2. Efficacy of rituximab in treating steroid-resistant Graves’ orbitopathy in active moderate-to-severe and sight-threatening forms: A retrospective observation from China;Heliyon;2024-06

3. Prospects for targeted therapy of Graves' disease: A review;Consilium Medicum;2024-05-20

4. Disease Modulation Versus Modification: A Call for Revised Outcome Metrics in the Treatment of Thyroid Eye Disease;Ophthalmic Plastic & Reconstructive Surgery;2024-01-25

5. Dysthyroid Optic Neuropathy;Oculoplastic, Lacrimal and Orbital Surgery;2024